Tag: ACC 2017

ACC 2017: Dual anti-thrombotic approach has similar risk of bleeding to...

The GEMINI-ACS study, which was simultaneously presented at the 2017 scientific sessions of the American College of Cardiology (ACC; 17–19 March, Washington, DC, USA)...

Viagra may reduce cardiovascular outcomes after a first myocardial infarction

Daniel P Andersson (Department of Medicine, Karolinska Institutet, Unit of Endocrinology, Metabolism, and Diabetes, Karolinska University Hospital, Stockholm, Sweden) and others report in Heart...

ACC 2017: Meta-analysis supports use of RenalGuard in cardiovascular Interventional procedures

A new meta-analysis presented this week at the American College of Cardiology 66th Scientific Sessions (ACC; 17-19 March, Washington DC, UK) offers support to...

ACC 2017: FDA approves launch of CoreValve Evolut Pro

The FDA has approved Medtronic’s CoreValve Evolut Pro transcatheter aortic valve implantation (TAVI) device. This approval follows data for the device that were presented...

ACC 2017: Positive final results from ORION-1 phase II study of...

The Medicines Company and Alnylam Pharmaceuticals have announced positive final results from the ORION-1 Phase II study of inclisiran, an investigational, first-in-class PCSK9 synthesis...

ACC 2017: TAVI Linked with bleeding in the brain and neurological...

Of 84 older patients undergoing transcatheter aortic valve implantationt (TAVI), nearly a quarter developed new microbleeds in the brain after their procedure, according to...

ACC 2017: Embol-X and CardioGard do not reduce number of brain...

Two US Food and Drug Administration-cleared medical devices designed to remove potential vessel-blocking debris particles from the bloodstream during aortic valve replacement—EmbolX (Edwards LifeSciences)...

ACC 2017: “iFR may be the new standard” of physiological assessment...

Writing in The New England Journal of Medicine, Deepak L Bhatt (Brigham and Women’s Hospital and Vascular Center and Harvard Medical School, Boston, USA)...

ACC 2017: Mary Norine Walsh assumes American College of Cardiology presidency

Mary Norine Walsh has become president of the American College of Cardiology during the Convocation Ceremony held in conjunction with the society’s 66th Annual...

ACC 2017: Wrist-worn heart rate monitors less accurate than standard chest...

Researchers at Cleveland Clinic, Cleveland, USA, put five popular wrist-worn fitness trackers to the test to find out how accurately they gauge heart rate...

ACC 2017: Researchers sound alarm over Zika’s potentially harmful effects on...

As the Zika virus continues to spread globally, new evidence has emerged about the virus’s potentially detrimental effects on the heart, according to data...

ACC 2017: CardioMEMS HF system effective in reducing heart failure hospitalisations...

Late-breaking clinical research presented at the American College of Cardiology 66th Annual Scientific Sessions (ACC; 17-19 March, Washington, DC, USA) has shown treatment with...

ACC 2017: PCSK9 inhibitor evolocumab significantly reduces the risk of cardiovascular...

Data for a new drug that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) show that it is associated with a near 60% reduction in...

ACC 2017: Two-year rate of target lesion failure significantly higher with...

Two-year data from the ABSORB III study indicate that a bioresorbable vascular scaffold (Absorb, Abbott Vascular) is associated with a significantly higher rate of...

ACC 2017: No significant differences in two-year morality between bicuspid and...

Sung-Han Yoon (Cedars-Sinai Heart Institute, Los Angeles, USA) and others report in the Journal of the American College of Cardiology that all-cause mortality at...

ACC 2017: CoreValve non-inferior to surgery in intermediate-risk patients

Results from the SURTAVI clinical trial, which were presented today at the 2017 scientific sessions of the American College of Cardiology (17–19 March, Washington,...